Evidence map›Paper›PMID 40744695›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Evaluation of Mitochondrial Complex 1 Density with [

Laigao Chen, Gaia Rizzo, Christine Bulawa, Koene R A Van Dijk, Erica C Henning, Alain Martelli, Jeffrey Palmer, Avery McIntosh, Marko Pregel, Pengling Sun and 15 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Laigao ChenPfizer, Cambridge, Massachusetts; laigao.chen@pfizer.com.
Gaia RizzoInvicro, London, United Kingdom.
Christine BulawaPfizer, Cambridge, Massachusetts.
Koene R A Van DijkPfizer, Cambridge, Massachusetts.
Erica C HenningPfizer, Cambridge, Massachusetts.
Alain MartelliPfizer, Cambridge, Massachusetts.
Jeffrey PalmerPfizer, Cambridge, Massachusetts.
Avery McIntoshPfizer, Cambridge, Massachusetts.
Marko PregelPfizer, Cambridge, Massachusetts.
Pengling SunPfizer, Cambridge, Massachusetts.
Emmanuel AdewunmiImperial College Healthcare Trust, Hammersmith Hospital, London, United Kingdom.
Mark AldridgeInvicro, Needham, Massachusetts.
Jackson ChanDepartment of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom; and.
Roger N GunnInvicro, London, United Kingdom.
Mickael HuibanInvicro, London, United Kingdom.
Allan ListancoInvicro, London, United Kingdom.
Peter T LoudonPeter Loudon Consulting Ltd., Cambridge, United Kingdom.
Sara MozInvicro, London, United Kingdom.
Jan PasschierInvicro, London, United Kingdom.
Lauren SauvageInvicro, London, United Kingdom.
Rachel StewartInvicro, Needham, Massachusetts.
Lisa WellsInvicro, London, United Kingdom.
Eugenii A RabinerInvicro, London, United Kingdom.
Lawrence R CharnasPfizer, Cambridge, Massachusetts.
Richard J FestensteinImperial College Healthcare Trust, Hammersmith Hospital, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Friedreich ataxia is caused by mutations in the frataxin gene, leading to neurodegeneration and premature death from cardiac dysfunction. Loss of frataxin impacts mitochondrial complex 1 (MC1) activity, suggesting MC1 may be a potential biomarker of frataxin levels and function. Biomarkers evaluated by noninvasive techniques are needed to monitor disease progression and treatment effects in people with Friedreich ataxia.

Indexed as

Electron Transport Complex IFriedreich AtaxiaAdultAnimalsBrainDisease Models, AnimalFemaleFrataxinHumansIron-Binding ProteinsMaleMiceMiddle AgedPositron-Emission TomographyYoung AdultElectron Transport Complex IFrataxinIron-Binding Proteins[18F]BCPP-EFfrataxinFriedreich ataxiamitochondrial complex 1PET

Identifiers

PMID40744695
PMCPMC12410303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.